Knowledge Base / Therapist Insights / Founder Mental Health 09/09
Therapy for: Boston biotech founders.
A clinical brief on private-pay online therapy for founders and CEOs of biotechs in the Cambridge and Greater Boston ecosystem. Built for the work as it actually is: binary readouts, capital-cycle whiplash, board pressure, and a team you owe more than the paycheck.
9 sections
The quick takeaway
Biotech founders carry a load that the broader founder population does not fully share: binary clinical readouts, FDA timelines they cannot accelerate, capital that arrives and leaves on a different schedule than the science, and a board that is, by design, comparing them to other biotech CEOs at the same stage. The mental-health load is documented, the leading reason for not seeking help is privacy, and the structural fix is the same model used by the rest of the senior high-responsibility population: private-pay, telehealth, no third-party payer, records that live only with the clinician.
01 / Definition
What 'confidential' means when you are the CEO and the cap table is watching.
Therapy for biotech founders is private-pay, telehealth-only individual psychotherapy structured around the clinical and capital cycles that define this work. Sessions are paid for directly, documented only in the clinician's protected file, and explicitly designed not to appear in any company benefits pathway, insurance trail, or third-party administrator record.
Most patients use 'confidential' to mean my therapist will not gossip. Biotech founders mean something more specific. The working questions are concrete: does this therapy generate an insurance EOB visible inside the company's benefits administration; does it create a utilization record at a third-party EAP vendor; does the provider appear in any aggregator a future board candidate, IPO underwriter, or acquirer would touch during diligence. Private-pay, telehealth-only therapy is designed to answer those questions the same way every time. No third-party payer. No company-administered record. The clinician documents what is clinically necessary in their own protected file. The patient is the only person with default authority to release it.
The pressures that bring biotech founders to therapy.
Binary outcomes
Most of what you have built sits on top of a small number of clinical readouts whose outcomes are not gradient. The mental load of running a company whose value can change by an order of magnitude on a single Tuesday is its own category of stress.
Capital-cycle whiplash
The science runs on a multi-year timeline. The market runs on a quarterly one. Reconciling the two in your own head and across your team is a sustained cognitive load that does not look like work to anyone who is not doing it.
Board pressure
Your board has seen this movie before, in other companies that did and did not succeed. That experience is often valuable; it is also a chronic comparison environment, and the comparison runs in only one direction.
Responsibility for the team
Scientists who joined a small company because they believed in the program. Their mortgage, their visas, their kids' schools. The responsibility you feel is not abstract; it is named.
Isolation
There are not many people you can talk to about the parts of this job that actually keep you up. Other founders are competing for the same money. Your team needs you steady. Your spouse hears about the work but cannot fully share the load.
Identity fusion with the program
Most biotech founders did not start a company to be a CEO. They started because the science mattered. When the science struggles, the identity struggles, and the line between the two is often invisible until it is not.
From the research
Freeman and colleagues' 2019 entrepreneur mental health study (Small Business Economics) reported that 49 percent of entrepreneurs surveyed had one or more lifetime mental health conditions, with depression at roughly twice the comparison rate. Industry surveys consistently show that biotech leadership, in particular, runs higher than the general founder population on indicators of sustained occupational stress, with privacy and reputational concern as the dominant barriers to seeking care.1
Three structural facts founders tend to find clarifying.
The company EAP is a benefit, not a sanctuary.
Employee Assistance Programs are typically genuinely confidential as to session content and run by third-party vendors. They also produce a utilization record at the aggregate level and create a relationship with a vendor that the company can reach. For a founder whose threat model includes future financing, M&A, or board considerations, that record is a real, if narrow, exposure.
Insurance is a privacy choice, not a default.
Running therapy through company-provided insurance is a choice with downstream consequences. The EOB exists. The claim exists in the payer's system. None of that is improper, but for a CEO it is often the wrong choice for a private clinical conversation about the company.
Help-seeking is documented as protective.
Across the broader cleared and senior-professional population, the empirical literature is consistent: seeking care is associated with better functional outcomes and is treated as a sign of good judgment in modern adjudicative frameworks. Avoidance of care, especially in the presence of a condition affecting judgment, is the risk factor.
Who tends to find this model useful.
Boston biotech founders are not a single profile. Three groups recur often enough across the Kendall Square and Seaport ecosystems to be worth naming.
Pre-clinical and Phase 1 founders
Founders running early-stage programs where the value is mostly future, the team is small, and every hire matters. The clinical work is often about how to sustain conviction over a multi-year horizon without losing the capacity to update on new data.
Late-stage and pre-readout founders
Founders running pivotal trials or approaching binary readouts, often with public company exposure or substantial private commitments. The presenting issue is often sleep, alcohol, or relationship strain; the underlying issue is sustained vigilance with no clean stopping point.
Post-readout and transition founders
Founders whose program hit or missed, who are now navigating an IPO, an acquisition, a restructuring, or a transition out of the CEO role. The conversation is often about distinguishing real signal from event-fatigue noise.
02 / Telehealth
Why telehealth fits the working life of a biotech founder.
Investor weeks, JPM, board meetings, and pre-readout periods compress everything. The defining variable is whether a 50-minute session survives a Friday afternoon DSMB call, a Sunday redline of an S-1, or a 5 a.m. flight to a sub-investigator site. Sessions from your own office, on your own calendar, are the only format that holds.
A clinician who has seen this job before
You should not have to explain what a DSMB is, what a Type B meeting feels like, or what it is to wait three weeks for top-line. The clinicians in our network are experienced with founders and senior executives in high-stakes industries.
Sessions that fit a biotech calendar
Evening and weekend availability is standard. Sessions are 50 minutes by default; 90-minute extended sessions and three-hour intensive sessions are available where indicated. Roadshow and conference weeks are handled directly with your clinician.
Records that stay outside the company
Your file lives with your clinician. There is no insurance claim, no EOB, no third-party administrator. HIPAA and the applicable state mental-health confidentiality statute set the floor; private-pay removes the systems that would otherwise create additional records.
03 / Mechanism
How a private-pay, telehealth-only structure changes the disclosure calculus.
Three structural choices, taken together, produce the privacy profile biotech founders are usually asking about: a clinician paid directly rather than through company-provided insurance, sessions delivered over a HIPAA-compliant platform from a location you control, and records that live only in the clinician's protected file under HIPAA and applicable state mental-health confidentiality law.
Company-provided insurance generates Explanations of Benefits, diagnostic codes attached to claims, and a record in a third-party payer's system. Your team typically cannot see clinical content, but the existence of the claim, the provider, and the dates are part of an architecture you do not fully control once you are at any scale.
Private-pay therapy removes those records entirely. There is no claim, no EOB, no third-party administrator, and no aggregated benefits utilization record. The clinician documents the session in their own chart, governed federally by HIPAA and at the state level by Massachusetts' mental-health privacy law (G.L. c.123 §36 and related provisions) when applicable. Both regimes treat psychotherapy notes as among the most protected categories of medical information in the system.
Telehealth completes the picture. You meet from your own office with the door closed, from home before the day starts, or from a hotel during a roadshow. CEREVITY clinicians are independent licensed psychologists and therapists who together cover all 50 states, including Massachusetts and the surrounding biotech corridor.
Standard advice vs. CEREVITY
Standard therapy
"We need a diagnosis code for your insurance claim before we can schedule."
CEREVITY
"There is no insurance claim and no diagnosis code on a payer's record. Your clinician documents what is clinically necessary, in their own protected file under HIPAA and Massachusetts mental-health privacy law where applicable."
Standard therapy
"Our next opening is in eleven weeks at 3 p.m. on Tuesday. That is the slot."
CEREVITY
"Evening and weekend sessions are standard. We work around DSMB meetings, board cycles, and JPM. Sessions that have to move do so with a phone call."
Standard therapy
"Please come in to our Back Bay office. Sign in with the building."
CEREVITY
"You meet from your own office, from home, or from a hotel during travel. Nothing about the session appears on your company calendar, building system, or benefits record."
| Standard insurance-based therapy | CEREVITY |
|---|---|
| "We need a diagnosis code for your insurance claim before we can schedule." | "There is no insurance claim and no diagnosis code on a payer's record. Your clinician documents what is clinically necessary, in their own protected file under HIPAA and Massachusetts mental-health privacy law where applicable." |
| "Our next opening is in eleven weeks at 3 p.m. on Tuesday. That is the slot." | "Evening and weekend sessions are standard. We work around DSMB meetings, board cycles, and JPM. Sessions that have to move do so with a phone call." |
| "Please come in to our Back Bay office. Sign in with the building." | "You meet from your own office, from home, or from a hotel during travel. Nothing about the session appears on your company calendar, building system, or benefits record." |
Quick break
A brief, confidential consultation is the right next step.
If any of the above is recognizable, the useful next action is a 20-minute consultation with a licensed clinician to determine fit. There is no obligation to continue.
04 / Cases
Common challenges we address.
Sustained operational anxiety the founder has stopped noticing.
The patternSleep has been poor for a long time. Caffeine is up; alcohol is up to match. The Sunday-evening dread is consistent. The working theory is that this is what running a biotech requires and that the feeling will lift after the next readout, the next financing, the next reorganization.
What we addressCognitive behavioral therapy applied to the cognitions that keep a founder awake, paired with concrete behavioral protocols for sleep, alcohol, and recovery between high-load periods. ACT and mindfulness-based work add capacity to notice the body before it has to escalate.
Identity fusion with the program that has gotten in the way of judgment.
The patternYou can no longer cleanly tell the difference between what is good for the science and what is good for you. The board has noticed even if no one has said so. The honest version of any conversation about the program now requires a few drinks to start.
What we addressPsychodynamic and schema-informed work on the patterns underneath the fusion. Explicit work on the difference between leading a program and being one. CBT and ACT layered in where structured, near-term change is also needed.
05 / Methods
Evidence-based treatment approaches.
Two clinical patterns come up often enough in this population to describe concretely. Neither is universal; both are recognizable.
Cognitive Behavioral Therapy (CBT)
First-line, time-limited, evidence-based work on the thought and behavior patterns that drive anxiety and depression. Useful when the picture is acute or when the patient prefers a structured approach with measurable change.
Acceptance and Commitment Therapy (ACT)
Useful when the issue is not faulty thinking but a values-action gap. ACT works on what the founder actually wants their life to be about and the moves that close the distance, without pretending the company is not real.
Behavioral activation
Targeted, structured work on the activities that have dropped out under sustained workload. For biotech founders, that is often physical activity, time with family, and any pursuit that is not instrumental to the program.
Schema-informed therapy
For the recurring patterns that began earlier and now show up in board relationships, co-founder dynamics, and self-evaluation. Schema work names the lenses through which the founder reads their situation.
Mindfulness-based interventions
Secular, evidence-supported practices for nervous-system regulation, sleep, and the in-the-moment capacity to step out of CEO mode. Clinically indicated for sustained high-stress work.
06 / Investment
Understanding the investment in private-pay care.
The clinical methods most often used.
At CEREVITY, our online individual therapy sessions are structured as a direct investment in your mental agility and overall well-being. The investment includes:
- Licensed mental health professional specializing in founder and executive mental health
- Evidence-based, one-on-one approaches proven effective for anxiety, depression, burnout, and acute stress around clinical readouts and capital events
- Flexible online scheduling including evenings and weekends
- Complete privacy with no insurance involvement or red tape
- biotech founders expertise and understanding
- Outcome tracking and progress measurement
The cost of biotech founder stress going unaddressed
Consider what is at stake when biotech founder stress goes unaddressed:
The professional cost of waiting
Untreated anxiety and depression degrade exactly the capacities a biotech CEO needs: judgment under fatigue, ability to update on contradictory data, regulation under board pressure, and the durability needed to lead a team through a hard quarter.
The personal cost of waiting
Spouses, partners, and children are the second audience of an untreated stress condition. The founders we see most often are those whose home life has reached a point that they cannot keep attributing to a passing milestone. The work is not separable from the rest of the life.
07 / Evidence
What the research shows.
Founder mental health is a documented occupational concern. Freeman and colleagues (Small Business Economics, 2019) reported that 49 percent of entrepreneurs surveyed met criteria for one or more lifetime mental health conditions, with depression at roughly twice the rate of a comparison sample, and ADHD, bipolar spectrum, and substance use at elevated rates. Subsequent industry and practitioner work has converged on the same drivers: chronic uncertainty, identity fusion with the venture, capital-cycle volatility, and persistent isolation.
Biotech leadership specifically operates in an environment of binary outcomes (clinical readouts), regulator-controlled timelines (FDA), and capital cycles that decouple short-term valuation from long-term scientific progress. The literature on burnout (Maslach and Leiter, 2016; WHO ICD-11, 2019) and on entrepreneurial well-being is consistent: the leading barriers to care are time, privacy, and professional reputation concerns. The structural response to those barriers is the model described in this article: care that does not generate an insurance trail, does not run through a company-administered program, and lives only in the clinician's protected file.
§ / Recap
Key takeaways.
Five things to remember
- The job's mental-health load is real and documented. Founder mental health is a documented occupational concern, with biotech leadership at the higher end of the curve. Treating it as such, and treating care as protective rather than indulgent, is the first move.
- Confidentiality is structural. Privacy is a function of how the engagement is paid for and where the records live. Private-pay, telehealth-only keeps the work entirely outside the company's benefits architecture.
- Help-seeking is the dominant evidence base. Across senior professional populations, the consistent finding is that seeking care is associated with better functional outcomes. Avoidance of care, in the presence of a condition that affects judgment, is the risk factor.
- Telehealth is the preferred default. Online individual therapy from a location the founder controls produces the most consistent attendance, the lowest logistical friction, and the smallest exposure surface. It is the structural fit for this work.
- CEREVITY provides this through online individual therapy nationwide, with full privacy through its private-pay concierge network and no insurance involvement.
08 / FAQ
Frequently asked questions.
Will my board, my investors, or a future acquirer learn that I am in therapy?
Not through CEREVITY. There is no insurance claim, no Explanation of Benefits, no third-party administrator, and no company-administered Employee Assistance Program involved in our private-pay, telehealth-only structure. Your sessions are paid for directly, your clinician documents what is clinically necessary, and that record is governed by HIPAA and Massachusetts (or your state's) mental-health confidentiality law. The common ways therapy becomes visible to a company are (1) insurance claims that generate EOBs, (2) EAP records held by a third-party administrator that reports usage data, and (3) benefits cards or expense reports that name a provider. Private-pay therapy removes all three.
I am about to enter a sensitive period (a pivotal readout, an IPO, an M&A process). Should I start before or after?
Before, if you can. The most useful time to start is before the period that you know is going to test you, not in the middle of it. Starting early lets the clinician understand your baseline and your patterns; starting inside a high-stakes window means doing both at the same time. That said, beginning during a sensitive period is also entirely reasonable and is what most founders actually do.
I travel constantly for fundraising and sub-investigator sites. Does that complicate care?
Telehealth licensure is governed by where the patient is located at the time of the session. CEREVITY's clinicians are independent licensed psychologists and therapists who together cover all 50 states; we match you with a clinician credentialed to see you in your primary jurisdiction and plan around travel in advance. International sessions involve their own constraints and we work through them on a case-by-case basis.
How does your private-pay pricing structure work?
As a private-pay concierge network, we offer structured investments in your mental health without the restrictions or privacy risks of insurance. You can review our full fee schedule and specific session lengths directly on our website. While this costs more than insurance copays, it provides the flexibility, total privacy, and highly specialized care that standard options cannot offer. View our current rates here.
How do you protect my privacy?
Privacy is foundational to our network. As a private-pay network, your sessions never appear on insurance records or EOBs that could be seen by employers, boards, or family members. We use HIPAA-compliant nationwide telehealth platforms, and you can attend sessions from anywhere with a private internet connection.
09 / Begin
Begin with a consultation, not a commitment.
The first conversation is 20 minutes with a licensed clinician. Private-pay, telehealth, no obligation to continue. Most founders find that one consultation tells them whether the model fits the period they are in.
Available by appointment 7 days a week, 8 AM to 8 PM (PST)§ / Author
About Trevor Grossman, PhD.
Trevor Grossman, PhD
Dr. Grossman is a Licensed Psychologist with more than 15 years of clinical experience working with entrepreneurs, founders, senior executives, and high-responsibility professionals navigating burnout, anxiety, and depression. His work integrates cognitive behavioral therapy, acceptance and commitment therapy, behavioral activation, and schema-informed approaches calibrated to the working week his clients are actually living in. He sees clients via CEREVITY's nationwide telehealth network. View full bio →
§ / Sources
References.
- Freeman MA, Staudenmaier PJ, Zisser MR, Andresen LA. The prevalence and co-occurrence of psychiatric conditions among entrepreneurs and their families. Small Business Economics. 2019;53(2):323-342. https://link.springer.com/article/10.1007/s11187-018-0059-8
- Maslach C, Leiter MP. Understanding the burnout experience: recent research and its implications for psychiatry. World Psychiatry. 2016;15(2):103-111. https://pmc.ncbi.nlm.nih.gov/articles/PMC4911781/
- World Health Organization. Burn-out an "occupational phenomenon": International Classification of Diseases (ICD-11). 2019. https://www.who.int/news/item/28-05-2019-burn-out-an-occupational-phenomenon-international-classification-of-diseases
- Stephan U. Entrepreneurs' mental health and well-being: a review and research agenda. Academy of Management Perspectives. 2018;32(3):290-322. https://journals.aom.org/doi/10.5465/amp.2017.0001
- Patzelt H, Shepherd DA. Negative emotions of an entrepreneurial career: self-employment and regulatory coping behaviors. Journal of Business Venturing. 2011;26(2):226-238. https://www.sciencedirect.com/science/article/abs/pii/S0883902609000913
Crisis resources
If you are experiencing a mental health crisis or having thoughts of suicide, please reach out immediately. 988 Suicide & Crisis Lifeline · Call or text 988 Crisis Text Line · Text HOME to 741741 National Alliance on Mental Illness · 1-800-950-NAMI (6264)
